The slip
PARKINSON RECEIPTno. 7340
23 Oct 2026, 08:04 UTCmicroglia, braak
predictionMEF2A in microglia tracks Braak Lewy-body stage
registered77af437adbd0d314
discovery+0.09 p=0.821 n=9
replication+0.25 p=0.523 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.09, p 0.821)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf8689b72b68ea8eb6c5f18a5…
follows 6be4b7a8046c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7340: MEF2A in microglia, braak
- power
- full sample +0.17 (p 0.498, n 18), 95% CI -0.32 to +0.59. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.22 (p 0.379, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.18 (p 0.471, n 18). could be the mix.
- skeptic
- leave-one-out range +0.07 to +0.30, sign flips 0; without severely affected donors +0.17 (p 0.498, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MEF2A in microglia.
case closed: nothing better to follow up.